TET2 has endothelial-specific roles in interferon responses that are dysregulated by hyperglycemia in vitro and in vivo
Open Access
- 25 July 2025
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (9) , 110520
Abstract
No abstract availableKeywords
Funding Information
- British Heart Foundation (PG/18/76/34098)
- British Heart Foundation (FS/18/60/34181)
- British Heart Foundation (FS/4yPhD/F/21/3415)
This publication has 109 references indexed in Scilit:
- A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver diseaseReviews in Endocrine and Metabolic Disorders, 2023
- The Effects of Hyperglycemia on Early Endothelial Activation and the Initiation of AtherosclerosisThe American Journal of Pathology, 2022
- The role of interferon-γ in cardiovascular disease: an updateInflammation Research, 2020
- Identification of hub‐methylated differentially expressed genes in patients with gestational diabetes mellitus by multi‐omic WGCNA basing epigenome‐wide and transcriptome‐wide profilingJournal of Cellular Biochemistry, 2019
- Low Shear Stress Inhibited Endothelial Cell Autophagy Through TET2 DownregulationAnnals of Biomedical Engineering, 2015
- Interferon-gamma induced adipose tissue inflammation is linked to endothelial dysfunction in type 2 diabetic miceBasic Research in Cardiology, 2011
- High glucose and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activityAtherosclerosis, 2009
- Hyperglycaemia and cardiovascular riskActa Diabetologica, 2003
- Interferon‐γ inhibits 35S incorporation in heparan sulfate synthesized by human skin fibroblastsFEBS Letters, 1996
- Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha,-beta, and-gammaArchives of Dermatological Research, 1989